Metraipolis › archive › dc_17124384e700

The discovery of Bevacizumab. An historical reappraisal — Europe PMC PMID:41105169

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41105169
DOI
10.1007/s10238-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-09T05:46:52.473Z
SHA-256 of the archived text
1808a00fa301b689f640456d567cb6fdff5d5f7ce70cd8aa0ec0deff60c456ce
Stable URL of this page
https://metraipolis.com/documento/dc_17124384e700

How to cite

The discovery of Bevacizumab. An historical reappraisal — Europe PMC PMID:41105169 — Europe PMC (en), https://europepmc.org/article/MED/41105169 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_17124384e700 (Metraipolis archive dc_17124384e700, sha256 1808a00fa301b689f640456d567cb6fdff5d5f7ce70cd8aa0ec0deff60c456ce)
BibTeX
@misc{dc17124384e700,
  title = {The discovery of Bevacizumab. An historical reappraisal — Europe PMC PMID:41105169},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41105169},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_17124384e700; sha256 1808a00fa301b689f640456d567cb6fdff5d5f7ce70cd8aa0ec0deff60c456ce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41105169. Agents can read the archived copy with the MCP tool read_document.